Repare Therapeutics Inc (RPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 53,477 | 51,133 | 131,830 | 7,600 | 135 |
| Gross Profit | 53,477 | 51,133 | 131,830 | 7,600 | 135 |
| Operating Expenses | 147,000 | 167,357 | 151,626 | 116,260 | 54,437 |
| Operating Income | -93,523 | -116,224 | -19,796 | -108,660 | -54,302 |
| Other Income | 10,274 | 13,045 | 5,896 | 74 | -440 |
| Pre-tax Income | -83,249 | -103,179 | -13,900 | -108,586 | -54,742 |
| Income Tax | 1,440 | -9,383 | 15,147 | -1,678 | -1,325 |
| Net Income Continuous | -84,689 | -93,796 | -29,047 | -106,908 | -53,417 |
| Net Income | $-84,689 | $-93,796 | $-29,047 | $-106,908 | $-53,417 |
| EPS Basic Total Ops | -2.00 | -2.23 | -0.69 | -2.83 | -2.66 |
| EPS Basic Continuous Ops | -2.00 | -2.23 | -0.69 | -2.83 | -2.66 |
| EPS Diluted Total Ops | -2.00 | -2.23 | -0.69 | -2.83 | -2.66 |
| EPS Diluted Continuous Ops | -2.00 | -2.23 | -0.69 | -2.83 | -2.66 |
| EPS Diluted Before Non-Recurring Items | -1.97 | -2.23 | -0.69 | -2.83 | -2.66 |
| EBITDA(a) | $-96,759 | $-121,738 | $-20,051 | $-107,076 | $-53,405 |